The global pharmaceutical market has recently shifted its focus from small molecule drugs to
peptide, protein, and nucleic acid drugs, which now comprise a majority of the top-selling …

Introduction Vaccines represent he most common and safer ways of combating infectious
diseases. Loss of potency owing to thermal denaturation or degradation of almost all the …

Distribution and delivery of Coronavirus 2019 (COVID-19) vaccines have become
challenging after their emergence. Today's platforms and systems leveraged for managing …

Improving the thermal stability of biologics, including vaccines, is critical to reduce the
economic costs and health risks associated with the cold chain. Here, we designed a …

Pharmaceutical companies, upstream suppliers, associated logistics providers, health
workers, regulatory agencies, public health experts and ultimately the medical practitioners …

The invaluable health, economic and social impacts of vaccination are hard to exaggerate.
The ability to stabilize vaccines is urgently required for their equitable distribution without the …

The urgency to develop vaccines against Covid-19 is putting pressure on the long and
expensive development timelines that are normally required for development of lifesaving …

Protection against primarily respiratory infectious diseases, such as tuberculosis (TB), can
likely be enhanced through mucosal immunization induced by direct delivery of vaccines to …

Glucan particles (GPs) are hollow, porous microspheres derived from Saccharomyces
cerevisiae (Baker's yeast). The hollow cavity of GPs allows for efficient encapsulation of …

Bacteriophages (phages) have gained considerable attention as effective antimicrobial
agents that infect and kill pathogenic bacteria. Based on this feature, phages have been …